Tag: regulatory audit observations

Common Regulatory Audit Observations During Multicenter Trials

Posted on digi By digi

Common Regulatory Audit Observations During Multicenter Trials Frequent Regulatory Audit Observations in Multicenter Clinical Trials Introduction: Why Multicenter Trials Pose Unique Compliance Risks Multicenter clinical trials offer sponsors the ability to enroll large, diverse patient populations across different geographies, enhancing the statistical power and generalizability of study results. However, the complexity of coordinating numerous sites…

Read More “Common Regulatory Audit Observations During Multicenter Trials” »

General Audit Findings in Clinical Trials, Regulatory Audit Findings

Common Challenges During the Consent Discussion in Clinical Trials

Posted on digi By digi

Common Challenges During the Consent Discussion in Clinical Trials How to Overcome Common Challenges in Consent Discussions for Clinical Trials Consent discussions are a pivotal part of clinical trial enrollment, ensuring that potential participants understand the study they are joining. However, these discussions often encounter several challenges that can compromise comprehension, voluntariness, and regulatory compliance….

Read More “Common Challenges During the Consent Discussion in Clinical Trials” »

Informed Consent and Ethics Committees, Informed Consent Process